Table 3:
Summary of previously published tandem occlusion series
| Authors, Year Published | Patients (No.) | % of TO Etiologiesa | TICI 2b/3 or TIMI 2–3 | mRS ≤2 | mRS 6 | sICH | Periprocedural Complications |
|---|---|---|---|---|---|---|---|
| Malik et al, 201121 | 77 | 100/0/0/0 | 58.0 (75.3)b | 32.0 (41.6) | 18.0 (23.4) | 8.0 (10.4) | NA |
| Kwak et al, 20132 | 35 | 100/0/0/0 | 26.0 (74.3) | 22.0 (62.9) | 4.0 (11.4) | 1.0 (2.9) | 0.0 (0.0) |
| Stampfl et al, 201423 | 24 | 100/0/0/0 | 15.0 (62.5) | 7.0 (29.2) | 4.0 (16.7) | 4.0 (16.7) | 1.0 (4.2) |
| Maurer et al, 201524 | 43 | 77/7/0/6 | 33.0 (76.7) | 14.0 (32.6) | 9.0 (20.9) | 5.0 (11.6) | 1.0 (2.3) |
| Cohen et al, 201525 | 24 | 100/0/0/0 | 19.0 (79.2) | 13.0 (54.2) | 2.0 (8.3) | 0.0 (0.0) | 0.0 (0.0) |
| Lockau et al, 20157 | 37 | 65/35/0/0 | 27.0 (73.0) | 17.0 (45.9) | 7.0 (18.9) | 4.0 (10.8) | 8.0 (21.6) |
| Spiotta et al, 201526 | 16 | 100/0/0/0 | 16.0 (100.0) | 8.0 (50.0) | 3.0 (18.8) | 2.0 (12.5) | 0.0 (0.0) |
| Lescher et al, 201513 | 39 | 28/18/54/0 | 25.0 (64.1) | 14.0 (35.9) | 4.0 (10.3) | 4.0 (10.3) | 0.0 (0.0) |
| Behme et al, 201527 | 170 | 100/0/0/0 | 130.0 (76.5) | 62.0 (36.5) | 32.0 (18.8) | 15.0 (8.8) | NA |
| Grigoryan et al, 201615 | 100 | 89/11/0/0 | 88.0 (88.0) | 42.0 (42.0) | 20.0 (20.0) | NA | NA |
| Fahed et al, 201614 | 70 | 54/19/19/8 | 47.0 (67.1) | 33.0 (47.1) | 9.0 (13.4) | NA | 12.0 (17.1) |
| This series | 86 | 77/23/0/0 | 56.0 (65.1) | 41.0 (48.2) | 17.0 (20.0) | 11.0 (12.8) | 24.0 (27.9) |
| Atherothrombotic TOs | 66 | 42.0 (63.6) | 27.0 (41.5) | 15.0 (23.1) | 10.0 (15.2) | 22.0 (33.3) | |
| Dissecting TOs19 | 20 | 14.0 (70.0) | 14.0 (70.0) | 2.0 (10.0) | 1.0 (5.0) | 2.0 (10.0) |
Note:—NA indicates non-available data; TIMI, Thrombolysis in Myocardial Infarction.
a
Distribution of the TO etiologies in percentages: atheromatous/dissection/cardioembolic/other causes.
b
Recanalization assessed with the TIMI score.